Hepatocellular carcinoma screening: Difference between revisions
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
Revision as of 20:47, 3 September 2015
|
Hepatocellular carcinoma Microchapters |
|
Differentiating Hepatocellular carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatocellular carcinoma screening On the Web |
|
American Roentgen Ray Society Images of Hepatocellular carcinoma screening |
|
Risk calculators and risk factors for Hepatocellular carcinoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
According to the American Association of Liver Diseases recommendations, screening for hepatocellular carcinoma by ultrasound (US) is recommended among patients with hepatitis B, hepatitis C, and cirrhosis. Screening is also recommended for Asian men over the age of 40, Asian women over the age of 50, and African American.
Screening
Screening for hepatocellular carcinoma by ultrasound recommended for the following:
- Hepatitis B
- Hepatitis C
- Cirrhosis
- Asian men over the age of 40
- Asian women over the age of 50
- African American